Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.
Also called NCT01285999
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT01285999
-
- Other papers using this trial's data
- PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01285999. Randomized; single masking; primary purpose treatment. Start 2011-01 (actual); primary completion 2013-03 (actual). Results posted on 2024-11-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
- Acronym
- PTChina
- Condition
- Atherosclerosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- PROMUS Element Coronary Stent System
- Intervention (Device)
- TAXUS Liberté Coronary Stent System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01285999- Content hash
24132413615689704d43798a3377a1a6d871430bafbcaa77155ea90bf8708038